Open Access
Features of metabolic disorders and hormone replacement therapy in pre- and postmenopausal patients with non-insulin-dependent diabetes mellitus
Author(s) -
O. D. Stekolshchikova
Publication year - 1999
Publication title -
problemy èndokrinologii
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.124
H-Index - 5
eISSN - 2308-1430
pISSN - 0375-9660
DOI - 10.14341/probl11788
Subject(s) - medicine , diabetes mellitus , osteoporosis , hormone replacement therapy (female to male) , life expectancy , hyperlipidemia , disease , endocrinology , insulin , menopause , population , testosterone (patch) , environmental health
Currently, the world is witnessing an aging population and an increase in the number of diseases characteristic of the elderly. These include cardiovascular disease (CVD), atherosclerosis, osteoporosis, type 2 diabetes mellitus (DM) (non-insulin-dependent diabetes mellitus - NIDDM). Increasing life expectancy requires improving the quality of life of patients. Given the angioprotective effect of hormone replacement therapy (HRT), there is an increasing interest in its use in postmenopausal women for the prevention and treatment of menopausal disorders, atherosclerosis, and osteoporosis. Among the huge contingent of patients with hyperglycemia, almost 80% are patients with NIDDM, of which 65-70% are women. This fact provides a great scientific and practical interest in the features of metabolic disorders (hyperglycemia, hyperlipidemia) in postmenopausal women.